FormDSignal
47

Adela biotech raises $12M in Delaware incorporation

Company raise · Closed · FOSTER CITY, CA · Form D filed 2026-10-19

Adela, Inc., a biotechnology company based in Foster City, California, has closed a $12M offering under Regulation D exemption 6(b) with five investors. The offering closed on October 2, 2026, with no placement agent involved.

$10M+ raiseoperating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Lindsay MateoExecutive Officer, Director
David BonitaDirector
Paul BrownDirector
Daniel Diniz De CarvalhoExecutive Officer
Anne-Renee HartmanExecutive Officer
Maneesh JainDirector
David ScheerExecutive Officer, Director
Robert WeisskoffDirector
Alan WilliamsExecutive Officer
Abraham KometzDirector

Signed by Lindsay Mateo, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer